• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-206通过直接抑制丝裂原活化蛋白激酶激酶激酶13,以合成致死的方式损害c-Myc驱动的癌症。

microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13.

作者信息

Han Han, Chen Yuxing, Cheng Li, Prochownik Edward V, Li Youjun

机构信息

College of Life Sciences, Medical Research Institute, Wuhan University, Wuhan 430072, China.

Division of Hematology/Oncology, Children's Hospital of Pittsburgh of UPMC and The Department of Microbiology and Molecular Genetics, The University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15224, USA.

出版信息

Oncotarget. 2016 Mar 29;7(13):16409-19. doi: 10.18632/oncotarget.7653.

DOI:10.18632/oncotarget.7653
PMID:26918941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4941324/
Abstract

c-Myc (Myc) is one of the most frequently dysregulated oncogenic transcription factors in human cancer. By functionally screening a microRNA (miR) library, we identified miR-206 as being a synthetic lethal in Myc over-expressing human cancer cells. miR-206 inhibited MAP3K13, which resulted in Myc protein de-stabilization, and an inhibition of anchorage-independent growth and in vivo tumorigenesis by Myc over-expressing human cancer cells. Eliminating MAP3K13 by shRNA recapitulated the effects caused by miR-206, thus supporting the idea that miR-206's effect on Myc was mediated through MAP3K13. Conversely, enforced expression of MAP3K13 stabilized Myc by promoting its N-terminal phosphorylation and enhancing its transcriptional activity. Gene expression analyses of breast cancers expressing high levels of Myc indicated that low miR-206 expression and high MAP3K13 expression correlated with poor patient survival. The critical link between miR-206 and MAP3K13 in the development of Myc over-expressing human cancers suggests potential points of therapeutic intervention for this molecular sub-category.

摘要

c-Myc(Myc)是人类癌症中最常失调的致癌转录因子之一。通过对微小RNA(miR)文库进行功能筛选,我们确定miR-206在Myc过表达的人类癌细胞中具有合成致死作用。miR-206抑制丝裂原活化蛋白激酶激酶激酶13(MAP3K13),导致Myc蛋白不稳定,并抑制Myc过表达的人类癌细胞的非锚定依赖性生长和体内肿瘤发生。通过短发夹RNA(shRNA)消除MAP3K13可重现miR-206所引起的效应,从而支持miR-206对Myc的作用是通过MAP3K13介导的这一观点。相反,MAP3K13的强制表达通过促进其N端磷酸化并增强其转录活性来稳定Myc。对高表达Myc的乳腺癌进行基因表达分析表明,低miR-206表达和高MAP3K13表达与患者生存不良相关。miR-206与MAP3K13在Myc过表达的人类癌症发生发展中的关键联系提示了针对这一分子亚类的潜在治疗干预点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/324d57c6ce57/oncotarget-07-16409-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/7509e558328f/oncotarget-07-16409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/5f154dbaaff8/oncotarget-07-16409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/a91bb608e132/oncotarget-07-16409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/32a4f4041565/oncotarget-07-16409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/43e83fe8f091/oncotarget-07-16409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/264579461e87/oncotarget-07-16409-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/324d57c6ce57/oncotarget-07-16409-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/7509e558328f/oncotarget-07-16409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/5f154dbaaff8/oncotarget-07-16409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/a91bb608e132/oncotarget-07-16409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/32a4f4041565/oncotarget-07-16409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/43e83fe8f091/oncotarget-07-16409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/264579461e87/oncotarget-07-16409-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbfc/4941324/324d57c6ce57/oncotarget-07-16409-g007.jpg

相似文献

1
microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13.微小RNA-206通过直接抑制丝裂原活化蛋白激酶激酶激酶13,以合成致死的方式损害c-Myc驱动的癌症。
Oncotarget. 2016 Mar 29;7(13):16409-19. doi: 10.18632/oncotarget.7653.
2
ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.膜联蛋白A1通过核因子-κB和c-Myc在负反馈回路中抑制微小RNA-196a,以减少乳腺癌增殖。
Oncotarget. 2016 May 10;7(19):27007-20. doi: 10.18632/oncotarget.8875.
3
c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.c-MYC 调控的 miR-23a/24-2/27a 簇通过靶向 Sprouty2 促进乳腺癌细胞侵袭和肝转移。
J Biol Chem. 2013 Jun 21;288(25):18121-33. doi: 10.1074/jbc.M113.478560. Epub 2013 May 6.
4
c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.c-Myc抑制肿瘤抑制性微小RNA(let-7a、miR-16和miR-29b),并在尤因肉瘤细胞系中诱导细胞周期蛋白D2介导的细胞增殖。
PLoS One. 2015 Sep 22;10(9):e0138560. doi: 10.1371/journal.pone.0138560. eCollection 2015.
5
Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.抑癌 microRNA-22 通过沉默 c-Myc 结合蛋白抑制 E 盒结合 c-Myc 靶基因的转录。
Oncogene. 2010 Sep 2;29(35):4980-8. doi: 10.1038/onc.2010.241. Epub 2010 Jun 21.
6
ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc.ROCK 通过与 c-Myc 的相互作用在调节前列腺肿瘤生长中起关键作用。
Oncogene. 2014 Dec 4;33(49):5582-91. doi: 10.1038/onc.2013.505. Epub 2013 Dec 9.
7
A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.miR-26a/E2F7 反馈环路促进 ER 阳性乳腺癌对他莫昔芬耐药。
Int J Oncol. 2018 Oct;53(4):1601-1612. doi: 10.3892/ijo.2018.4492. Epub 2018 Jul 19.
8
A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.SUMOylation 依赖性转录亚程序是 Myc 驱动的肿瘤发生所必需的。
Science. 2012 Jan 20;335(6066):348-53. doi: 10.1126/science.1212728. Epub 2011 Dec 8.
9
miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.miR-181d 和 c-myc 介导的 CRY2 和 FBXL3 抑制作用重塑结直肠癌中的代谢。
Cell Death Dis. 2017 Jul 27;8(7):e2958. doi: 10.1038/cddis.2017.300.
10
Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.通过混合 shRNA 筛选鉴定 PRKDC 在 MYC 依赖性人类癌症中的合成致死性。
BMC Cancer. 2014 Dec 13;14:944. doi: 10.1186/1471-2407-14-944.

引用本文的文献

1
Advances in synthetic lethality modalities for glioblastoma multiforme.多形性胶质母细胞瘤合成致死模式的进展。
Open Med (Wars). 2024 Jun 10;19(1):20240981. doi: 10.1515/med-2024-0981. eCollection 2024.
2
Evolving copy number gains promote tumor expansion and bolster mutational diversification.不断进化的拷贝数增益促进肿瘤扩张并增强突变多样化。
Nat Commun. 2024 Mar 6;15(1):2025. doi: 10.1038/s41467-024-46414-5.
3
A gene mutation-based risk model for prognostic prediction in liver metastases.基于基因突变的肝转移预后预测风险模型。

本文引用的文献

1
Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.miR-362-3p的上调通过直接靶向肝细胞癌中的Tob2来调节细胞增殖和锚定非依赖性生长。
J Cell Biochem. 2015 Aug;116(8):1563-73. doi: 10.1002/jcb.25110.
2
MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.微小RNA-206在肝细胞癌中表达下调,可抑制细胞增殖并促进细胞凋亡。
Hepatogastroenterology. 2014 Jul-Aug;61(133):1302-7.
3
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma.
BMC Genomics. 2023 Aug 26;24(1):489. doi: 10.1186/s12864-023-09595-9.
4
Fast and powerful conditional randomization testing via distillation.通过蒸馏实现快速且强大的条件随机化测试。
Biometrika. 2022 Jun;109(2):277-293. doi: 10.1093/biomet/asab039. Epub 2021 Jul 8.
5
Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of Gene Fusion and Mutation: A Case Report and Comparison with Adult Cases in the Literature.具有基因融合和突变的小儿颅内黏液样间充质肿瘤的临床病理及基因组特征:1例报告并与文献中的成人病例比较
NMC Case Rep J. 2022 May 18;9:101-109. doi: 10.2176/jns-nmc.2021-0385. eCollection 2022.
6
Clinical significance of mitogen-activated protein kinase kinase kinases in hepatitis B virus -related hepatocellular carcinoma and underlying mechanism exploration.丝裂原活化蛋白激酶激酶激酶在乙型肝炎病毒相关性肝细胞癌中的临床意义及作用机制探讨。
Bioengineered. 2022 Mar;13(3):6819-6838. doi: 10.1080/21655979.2022.2037224.
7
LINC01287 facilitates proliferation, migration, invasion and EMT of colon cancer cells via miR-4500/MAP3K13 pathway.LINC01287 通过 miR-4500/MAP3K13 通路促进结肠癌细胞的增殖、迁移、侵袭和 EMT。
BMC Cancer. 2021 Jul 6;21(1):782. doi: 10.1186/s12885-021-08528-7.
8
Wallenda-Nmo Axis Regulates Growth via Hippo Signaling.瓦伦达-Nmo轴通过Hippo信号通路调控生长。
Front Cell Dev Biol. 2021 Apr 16;9:658288. doi: 10.3389/fcell.2021.658288. eCollection 2021.
9
KMT2D promotes proliferation of gastric cancer cells: evidence from ctDNA sequencing.KMT2D 促进胃癌细胞增殖:来自 ctDNA 测序的证据。
J Clin Lab Anal. 2021 Apr;35(4):e23721. doi: 10.1002/jcla.23721. Epub 2021 Apr 1.
10
Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs.抑制 miR-1193 导致缺乏 DNA-PKcs 的多形性胶质母细胞瘤细胞的合成致死。
Cell Death Dis. 2020 Jul 30;11(7):602. doi: 10.1038/s41419-020-02812-3.
CDK9 介导的转录延伸是肝癌中 MYC 成瘾所必需的。
Genes Dev. 2014 Aug 15;28(16):1800-14. doi: 10.1101/gad.244368.114.
4
MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival.MTBP在三阴性乳腺癌中过表达,并促进其生长和存活。
Mol Cancer Res. 2014 Sep;12(9):1216-24. doi: 10.1158/1541-7786.MCR-14-0069. Epub 2014 May 27.
5
Small-molecule inhibitors of the Myc oncoprotein.Myc癌蛋白的小分子抑制剂。
Biochim Biophys Acta. 2015 May;1849(5):525-43. doi: 10.1016/j.bbagrm.2014.03.005. Epub 2014 Mar 19.
6
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA.结合多维基因组测量以预测癌症预后:来自癌症基因组图谱(TCGA)的观察结果
Brief Bioinform. 2015 Mar;16(2):291-303. doi: 10.1093/bib/bbu003. Epub 2014 Mar 13.
7
The Cancer Genome Atlas: clinical applications for breast cancer.癌症基因组图谱:乳腺癌的临床应用。
Oncology (Williston Park). 2013 Dec;27(12):1263-9, 1274-9.
8
A high-throughput siRNA screening platform to identify MYC-synthetic lethal genes as candidate therapeutic targets.一个用于鉴定MYC合成致死基因作为候选治疗靶点的高通量小干扰RNA筛选平台。
Methods Mol Biol. 2013;1012:187-200. doi: 10.1007/978-1-62703-429-6_12.
9
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis.转录因子 NRF2 调控 miR-1 和 miR-206 以驱动肿瘤发生。
J Clin Invest. 2013 Jul;123(7):2921-34. doi: 10.1172/JCI66353. Epub 2013 Jun 10.
10
A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis.c-Myc- MicroRNA 功能反馈环影响肝癌发生。
Hepatology. 2013 Jun;57(6):2378-89. doi: 10.1002/hep.26302.